Your session is about to expire
← Back to Search
Lithium for COVID-19
Study Summary
This trial will look at how low doses of lithium may help long COVID sufferers with their symptoms.
- COVID-19
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 4 trial • 46 Patients • NCT00596622Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your score on the Beck Depression Inventory II is less than 24.You have been experiencing tiredness and difficulty concentrating or remembering things for at least four weeks after having COVID-19.You feel very tired or have trouble thinking clearly, with scores of 28 or higher on the Fatigue Severity Scale or the Brain Fog Severity Scale.You have never had fibromyalgia, chronic fatigue syndrome, or any progressive cognitive disorder before getting infected with COVID-19.You haven't used tobacco or marijuana products for more than 6 months, and you are not currently abusing alcohol (drinking 4 or more drinks per day) or using illegal drugs.
- Group 1: Lithium
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the cohort size for this clinical investigation?
"Affirmative. Per the clinicaltrials.gov, this ongoing medical experiment was posted on November 18th 2022 and updated recently on the 14th of that same month. 50 individuals need to be recruited from a single site for successful completion of the trial."
Does this experiment accept volunteers older than 55 years old?
"The eligibility criteria for this medical research necessitates that applicants must be between 18 to 80 years old. An additional 1 study is available for individuals under the age of majority, and 20 studies are accessible to those over 65."
Does Lithium pose any health risks when administered correctly?
"Lithium's safety profile is estimated to be a 2 on a scale of 1-3, as the Phase 2 trial that was conducted did not provide any evidence for its efficacy but did offer some data in regards to its security."
What outcomes is this research attempting to realize?
"The primary endpoint of this trial, monitored over a period from the initial baseline to day 21, is Brain Fog Severity Scale. Secondary metrics assessed include Sense of Smell and Taste Change Scale (subjectively gauging changes compared to the beginning), Headache and Body Pain Bother Scale (2-item questionnaire ascertaining headaches and body pain frequency in the last week) as well as Generalized Anxiety Disorder-2 Scale (two questions probing anxiety levels experienced during that same time frame)."
Who meets the criteria for participation in this research endeavor?
"This trial requires 50 individuals afflicted with long covid, ranging in age from 18 to 80. In order to be eligible for enrollment, applicants must pass the following criteria: Documented or self-reported positive COVID test at least one month before applying; no fever during that period either; reports of fatigue and/or brain fog (e.g., concentration issues or memory problems) lasting ≥4 weeks post COVID infection; Fatigue Severity Scale score ≥28 or Brain Fog Severity Score≥28 baseline; Beck Depression Inventory II <24; no changes in meds like psychoactive substances and steroids within 30 days prior nor"
Is there an ongoing recruitment of participants for this research?
"Affirmative. The trial, which was initially uploaded to clinicaltrials.gov on November 18th 2022 is actively seeking patients for recruitment; 50 volunteers across 1 sites are sought after."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger